Based on the positive results of these clinical trials, the American Diabetes Association and European Association for the Study of Diabetes Consensus Report recommend the use of GLP-1RAs for treating patients with T2DM with atherosclerotic CVD and/or multiple coronary risk factors [8]
However, it was not possible to detect them in the short study period [46]
However, a 2017 study found BPC-157 actually reduced tumor growth in colon cancer models by 45% (Tkalcevic et al., 2017)
If youre ready to explore a safe, physician-led approach to weight loss, book a consultation today and take the first step toward lasting health
Not in your complete blood count
Most of whats known comes from animal studies, anecdotal reports, and underground use, leaving big questions around safety, purity, and long-term effects